Oxford Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,681
Closed -$258K 1564
2019
Q4
$258K Buy
5,681
+620
+12% +$29.3K 0.01% 1485
2019
Q3
$232K Buy
+5,061
New +$284K 0.01% 1539
2018
Q2
Sell
-6,042
Closed -$239K 2003
2018
Q1
$239K Buy
+6,042
New +$235K 0.01% 1455
2017
Q4
Sell
-31,469
Closed -$803K 1932
2017
Q3
$803K Sell
31,469
-96,236
-75% -$2.21M 0.02% 1035
2017
Q2
$2.15M Buy
127,705
+19,514
+18% +$268K 0.04% 574
2017
Q1
$1.58M Buy
108,191
+40,082
+59% +$594K 0.04% 605
2016
Q4
$967K Buy
68,109
+51,969
+322% +$805K 0.03% 484
2016
Q3
$282K Buy
+16,140
New +$268K 0.01% 674
2015
Q4
Sell
-26,418
Closed -$505K 981
2015
Q3
$505K Sell
26,418
-70,427
-73% -$2.39M 0.02% 496
2015
Q2
$4.49M Buy
+96,845
New +$4.2M 0.12% 198
2015
Q1
Sell
-93,724
Closed -$3.26M 778
2014
Q4
$3.26M Buy
+93,724
New +$3.8M 0.07% 271
2013
Q3
Sell
-2,000
Closed -$154K 941
2013
Q2
$154K Buy
+2,000
New +$163K ﹤0.01% 811

Other funds holding ARNA

Oxford Asset Management's ARNA Position: Q1 2020 in Review

Oxford Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 5,681 shares — an estimated $258K sold.

Oxford Asset Management first reported a position in ARNA in Q2 2013 and held it in 12 quarters. The position peaked at $4.49M in Q2 2015. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • Oxford Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 5,681 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $258K.
  • Oxford Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Oxford Asset Management's Arena Pharmaceuticals Inc position peaked at $4.49M in Q2 2015.
  • 219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.